Anchoring bias in emergency medicine leads to missed diagnosis of pulmonary embolism

NewsGuard 100/100 Score

Findings

Finding evidence of what is known as "anchoring bias," UCLA-led research suggests that patients with congestive heart failure experiencing shortness of breath are less likely to be tested in the emergency department for a potentially fatal pulmonary embolism, or a blood clot in the lung, when the reason for the visit noted during the initial emergency department check-in process specifically mentions congestive heart failure instead of the broader "shortness of breath". Specifically, the authors found in this study that when the visit reason mentioned a patient's known congestive heart failure, the likelihood that the emergency room physician would test the patient for pulmonary embolism was reduced by one-third, even though that could be the cause of the shortness of breath. Rates of pulmonary embolism within 30 days of the emergency department visit were equal between patients with visit reasons that mentioned congestive heart failure and patients that did not have such visit reasons, suggesting that anchoring bias may have led to delays in diagnosis.

Background

Cognitive biases are believed to influence physician decision making. Among them is anchoring bias, which is when a physician focuses on a single, initial piece of information in the clinical decision-making process without sufficiently considering subsequent information about the patient's condition.

Method

The researchers examined Veterans Affairs data from 108,000 patients with congestive heart failure who went to emergency departments with shortness of breath between 2011 to 2018. They compared patients with visit reasons that mentioned their congestive heart failure to patients with visit reasons that were broader in nature.

Impact

Anchoring bias can delay crucial testing for and diagnosis of deadly medical conditions such as pulmonary embolism.

Comment

"We find evidence that anchoring bias can lead physicians astray," said lead author Dr. Dan Ly, assistant professor of medicine in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA. "When a more specific diagnosis is suggested early on, even before the physician has met the patient, physicians can 'anchor' on this diagnosis and miss important and dangerous alternative conditions. It's important for physicians to be aware of such cognitive biases and keep an open mind, and for those on the medical team not to anchor their colleagues when relaying information."

Authors

Additional study authors are Dr. Paul Shekelle of Veterans Affairs, Greater Los Angeles Healthcare System, and Dr. Zirui Song of Harvard University. Ly is also affiliated with Veterans Affairs, Greater Los Angeles Healthcare System.

Journal

The study will be published June 26 in JAMA Internal Medicine

Funding

This work was supported by the National Institute on Aging (F32 AG060650-02, P01 AG032952), the National Institute for Health Care Management, and Arnold Ventures (20-04402).

Source:
Journal reference:

Ly, D. P., et al. (2023) Evidence for Anchoring Bias During Physician Decision-Making. JAMA Internal Medicine. doi.org/10.1001/jamainternmed.2023.2366.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New RNA therapy zilebesiran shows promise in lowering blood pressure